Search results for "Early warning score"
showing 3 items of 3 documents
Overvåking av vitale parametere i sykehus : En sammenligning av manuelle og elektroniske overvåkingssystemer
2018
Masteroppgave i helse- og sosialinformatikk HSI500 - Universitetet i Agder 2018 Adverse events can be avoided by timely recognition of derangements in vital signs. Sørlandet Hospital HF (SSHF) has implemented an Early Warning Score System named "TILT"; 2Early identification of life-threatening conditions”. In 2017 SSHF started a project that tested wireless sensors for continuous monitoring of vital signs on wards. Patients were monitored by sensors and vital signs were also measured by traditional means during the project period. The aim of this study was to examine compliance with the vital signs monitoring protocol, and to examine the benefits of an electronic system. The following quest…
Physiological parameters for Prognosis in Abdominal Sepsis (PIPAS) Study: a WSES observational study
2019
Timing and adequacy of peritoneal source control are the most important pillars in the management of patients with acute peritonitis. Therefore, early prognostic evaluation of acute peritonitis is paramount to assess the severity and establish a prompt and appropriate treatment. The objectives of this study were to identify clinical and laboratory predictors for in-hospital mortality in patients with acute peritonitis and to develop a warning score system, based on easily recognizable and assessable variables, globally accepted. Background Timing and adequacy of peritoneal source control are the most important pillars in the management of patients with acute peritonitis. Therefore, early pr…
Phase I dose-escalation single centre clinical trial to evaluate the safety of infusion of memory T cells as adoptive therapy in COVID-19 (RELEASE)
2021
Abstract Background Effective treatments are still needed to reduce the severity of symptoms, time of hospitalization, and mortality of COVID-19. SARS-CoV-2 specific memory T-lymphocytes obtained from convalescent donors recovered can be used as passive cell immunotherapy. Methods Between September and November 2020 a phase 1, dose-escalation, single centre clinical trial was conducted to evaluate the safety and feasibility of the infusion of CD45RA− memory T cells containing SARS-CoV-2 specific T cells as adoptive cell therapy against moderate/severe cases of COVID-19. Nine participants with pneumonia and/or lymphopenia and with at least one human leukocyte antigen (HLA) match with the don…